Skip to main content
. Author manuscript; available in PMC: 2019 Dec 5.
Published in final edited form as: Leukemia. 2019 Jun 17;33(8):1835–1850. doi: 10.1038/s41375-019-0512-y

Figure 4. Potential future model for an enhanced risk classification by incorporation of genomic factors.

Figure 4.

Clinical risk assessed according to the EUTOS long-term survival score. Genomic risk may be classified as Low if no mutant genes of clinical relevance are detected, Intermediate if a mutation demonstrated to confer a moderate risk is detected, and High if specific mutations or multiple mutations are detected.